Marine Anti-inflammatory Agents |
Autore | Talero Elena |
Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
Descrizione fisica | 1 electronic resource (248 p.) |
Soggetto non controllato |
Tropical Eastern Pacific
Zoanthus pulchellus critical illness zoanthamine SPR analysis dendritic cells endothelial cell death T cell differentiation seafood waste microalgae pyrogallol-phloroglucinol-6 NRLP3 THP-1 macrophages fucoxanthin photo-protection cytokine thromboxane Isochrysis galbana fish oil photoprotection functional ingredients rosmarinic acid MAPK marine invertebrates poor blood circulation anti-inflammatory activity eicosapentaenoic acid anti-oxidative macroalgae colon inflammation MGDG TLR4 6-bieckol polyunsaturated fatty acid matrix metalloproteinases-9 (MMP-9) acute sickness behavior UVB eicosanoid clavulones carotenoids denervation polyunsaturated fatty acids skin epidermal hyperplasia Geodia barretti omega-3 parenteral nutrition inflammation ultraviolet B docosahexaenoic acid signal transducer and activator of transcription 3 (STAT3) anti-inflammatory zoantharia vascular smooth muscle cell proliferation and migration bioactive molecules polysaccharides lipopolysaccharide (LPS) glycolipids DSS colitis punaglandins marine nutraceuticals marine vertebrates phlorotannins acute lung injury (ALI) NF-?B diatoms interleukin (IL) inflammasome Frondanol Cucumaria frondosa prostaglandins Ecklonia cava 6-bromoindole NO inhibition surgery |
ISBN | 3-03921-573-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910367750303321 |
Talero Elena | ||
MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Targeting STAT3 and STAT5 in Cancer |
Autore | Moriggl Richard |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
Descrizione fisica | 1 electronic resource (578 p.) |
Soggetto topico |
Research & information: general
Biology, life sciences |
Soggetto non controllato |
multiple myeloma
STAT3 S3I-1757 nanoparticle CD38 siRNA/RNAi polyethylenimine PEI lipopolyplex siRNA delivery glioma glioblastoma STAT5 AKT ERK1/2 prolactin androgens prostate cancer knockout escape mechanisms stem/progenitor cells cell hierarchy cancer CD4+ T cells CD8+ T cells myeloid cells immune check point hepatitis C virus (HCV) cirrhosis hepatocellular carcinoma (HCC) endoplasmic reticulum (ER) stress oxidative stress (OS) unfolded protein response (UPR) microRNA-122 (miR-122) nuclear factor erythroid 2-related factor 2 (NRF2) signal transducer and activator of transcription 3 (STAT3) hepatocyte nuclear factor 4 alpha (HNF4A) solid cancers cell cycle apoptosis inflammation mitochondria stemness tumor suppression melanoma autoimmune disease immunotherapy tumor-immune cell interactions breast cancer PD-L1 M2 macrophages NK cells STAT3 inhibitor XIII hedging transaction costs dynamic programming risk management post-decision state variable cancer progression cancer-stem cell cytokine therapy resistance metastasis immunosuppression tumor microenvironment proliferation tyrosine kinase 2 JAK family of protein tyrosine kinases signal transducer and activator of transcription cytokine receptor signaling gain-of-function mutation tumorigenesis ADAM17 interleukin-6 trans-signaling epidermal growth factor receptor (EGF-R) shedding metalloprotease tumor necrosis factor alpha (TNFα) inflammation associated cancer colon cancer lung cancer SH2 domain mutations autosomal-dominant hyper IgE syndrome inflammatory hepatocellular adenomas T-cell large granular lymphocytic leukemia T-cell prolymphocytic leukemia growth hormone insensitivity syndrome nuclear pore complex nuclear transport receptors nucleocytoplasmic shuttling targeting tumor-associated macrophages adoptive T cell therapy immune suppression STAT transcription factors JAK STAT T-PLL T-cell leukemia meta-analysis STAT5B signaling small-molecule inhibitors cancer models companion animals comparative oncology pharmacological inhibitor STAT5 signaling chemotherapy resistance myeloid leukemia heat shock proteins chaperones stabilization targeted therapy ovarian cancer hematopoietic cancers therapeutic targeting pharmacological inhibitors mTOR Bone Marrow Failure Syndromes lymphocytes lymphoma T-cells RHOA NGS MPN JAK2 V617F neoplastic stem cells |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557623503321 |
Moriggl Richard | ||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|